atypical melanotic nevus - a Melanoma Precursor? Not Exactly Atypical Melanocytes | Skin Cancer

Melanotan-2 remains the only available pharmacological tool allowing the simultaneous study of the relative contributions of the four MCR receptors using selective antagonism protocols (HS024 for MC4R, JNJ-10229570 for MC3R, etc.)

Understanding each peptides receptor action, potency, and duration lets researchers pick the compound that fits their study goals

When MT-2 activates MC3R and MC4R, it can affect appetite and energy balance, so it is studied in metabolism research

It is illegal to sell medicinal products containing Melanotan II in the UK but as the tanners are sold cosmetically they fall outside that remit